 Quantitative analysis proviral DNA peripheral blood mononuclear cells patients AIDS ARC decrease proviral DNA content treatment ddI rapid simple method proviral DNA content peripheral blood mononuclear cells PBM patients human immunodeficiency virus type infection polymerase chain reaction PCR technique majority HIV proviral DNA copies detectable unfractionated PBM cells cells/monocytes amounts HIV DNA cells cells/monocytes amount HIV proviral DNA PBM patients AIDS AIDS-related complex ARC antiretroviral therapy ddI dose Phase clinical study significant decrease evaluable patients drug weeks decrease pronounced patients high doses drug data quantitation HIV viral DNA PBM PCR feasible overall monitoring patients experimental therapy studies sensitivity specificity assay longitudinal studies essential